Cargando…

Commentary: LRP1 Is a Master Regulator of Tau Uptake and Spread

Detalles Bibliográficos
Autores principales:	Fearon, Conor, Lynch, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786302/ https://www.ncbi.nlm.nih.gov/pubmed/33424736 http://dx.doi.org/10.3389/fneur.2020.557509

Ejemplares similares

LRP1 is a master regulator of tau uptake and spread
por: Rauch, Jennifer N., et al.
Publicado: (2020)

LRP1 is a neuronal receptor for α-synuclein uptake and spread
por: Chen, Kai, et al.
Publicado: (2022)

Elevated expression of cholesterol transporter LRP-1 is crucially implicated in the pathobiology of glioblastoma
por: N. R., Shruthi, et al.
Publicado: (2022)

Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism
por: Cooper, Joanna M., et al.
Publicado: (2021)

TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading
por: Martini-Stoica, Heidi, et al.
Publicado: (2018)

Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target
por: Oakley, Sebastian S., et al.
Publicado: (2020)

Commentary: Oxygen regulation of breathing through an olfactory receptor activated by lactate
por: Santillo, Mariarosaria, et al.
Publicado: (2016)

Clinical Characteristics and Prognosis of Anti-AChR Positive Myasthenia Gravis Combined With Anti-LRP4 or Anti-Titin Antibody
por: Chen, Yuping, et al.
Publicado: (2022)

Commentary: Learn from the master
por: Ikonomidis, John S.
Publicado: (2020)

Commentary: First master the fundamentals
por: Mascio, Christopher E., et al.
Publicado: (2021)

Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice
por: Zareba-Paslawska, Justyna, et al.
Publicado: (2021)

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
por: Alquezar, Carolina, et al.
Publicado: (2021)

Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us?
por: Houben, Sarah, et al.
Publicado: (2021)

sLRP1ng Up Glucose: LRP1 Regulates Hepatic Insulin Responses
por: Lee, Stephen D., et al.
Publicado: (2016)

Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology
por: Mothes, Tobias, et al.
Publicado: (2023)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

Tau Ubiquitination in Alzheimer's Disease
por: Li, Longfei, et al.
Publicado: (2022)

New Perception of Mitochondrial Regulatory Pathway in Parkinsonism – Ubiquitin, PINK1, and Parkin
por: Olszewska, Diana Angelika, et al.
Publicado: (2014)

Dynamics of Internalization and Intracellular Interaction of Tau Antibodies and Human Pathological Tau Protein in a Human Neuron-Like Model
por: Shamir, Dov B., et al.
Publicado: (2020)

Editorial: Tau Pathology in Neurological Disorders
por: Do Carmo, Sonia, et al.
Publicado: (2021)

Roles of Microglial and Monocyte Chemokines and Their Receptors in Regulating Alzheimer's Disease-Associated Amyloid-β and Tau Pathologies
por: Guedes, Joana R., et al.
Publicado: (2018)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
por: Duquette, Antoine, et al.
Publicado: (2021)

Antisense Oligonucleotide-Mediated Reduction of HDAC6 Does Not Reduce Tau Pathology in P301S Tau Transgenic Mice
por: Valencia, Antonio, et al.
Publicado: (2021)

Cellular Biology of Tau Diversity and Pathogenic Conformers
por: Kang, Sang-Gyun, et al.
Publicado: (2020)

Alterations in Tau Metabolism in ALS and ALS-FTSD
por: Strong, Michael J., et al.
Publicado: (2020)

Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
por: Canepa, Elisa, et al.
Publicado: (2021)

LDLR, LRP1, and Megalin redundantly participate in the uptake of Clostridium novyi alpha-toxin
por: Zhou, Yao, et al.
Publicado: (2022)

Editorial: Network Spread Models of Neurodegenerative Diseases
por: Raj, Ashish, et al.
Publicado: (2019)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
por: Bryant, Annie G., et al.
Publicado: (2020)

Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases
por: Diez, Lisa, et al.
Publicado: (2020)

Targeting Tau to Treat Clinical Features of Huntington's Disease
por: Masnata, Maria, et al.
Publicado: (2020)

Traumatic brain injury and the pathways to cerebral tau accumulation
por: Flavin, William P., et al.
Publicado: (2023)

Commentary: Detection Methods for Autoantibodies in Suspected Autoimmune Encephalitis
por: Gadoth, Avi
Publicado: (2019)

Commentary: Epilepsy in Leigh Syndrome With Mitochondrial DNA Mutations
por: Finsterer, Josef
Publicado: (2019)

The association between LRP1 and chylomicron uptake after the ingestion of a high-fat meal
por: Frazier-Wood, AC, et al.
Publicado: (2012)

CSF p-tau as a potential cognition impairment biomarker in ALS
por: Gong, Zhongying, et al.
Publicado: (2022)

Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling
por: Wan, Wenbin, et al.
Publicado: (2019)

Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2
por: Damen, Manon J., et al.
Publicado: (2022)

Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis
por: Zhang, Junjiao, et al.
Publicado: (2023)

Loss of visual feedback revealing motor impairment – an early symptom of Parkinson’s disease in two Irish farmers
por: Olszewska, Diana A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d8hq3fj2arlbvqn6e4c33ddko5